Select Medical stock hits 52-week low at 13.94 USD

Select Medical Holdings Corp (NYSE:SEM)’s stock reached a 52-week low, closing at $13.94, significantly below its 52-week high of $40.98. According to InvestingPro data, this marks a significant downturn for the company, with the stock declining nearly 29% over the past year. Despite the current market valuation of $1.8 billion, analysts maintain a bullish outlook with price targets ranging from $15 to $25. The healthcare services provider has faced challenges in the market, contributing to this decrease in stock value. However, the company maintains strong fundamentals with a 16.4% revenue growth and healthy free cash flow yield. Investors are closely monitoring the company’s performance and market conditions, as InvestingPro analysis suggests the stock is currently trading below its Fair Value, with additional insights available in the comprehensive Pro Research Report covering this and 1,400+ other US stocks.

In other recent news, Select Medical (TASE:BLWV) Holdings has been the focus of several analyst updates and strategic developments. UBS maintained a Neutral rating on Select Medical with a price target of $15, citing regulatory challenges in its Long-Term Acute Care Hospital (LTACH) segment as a concern. The company has faced issues due to regulatory changes, which affected its first-quarter results, but noted improvements in LTACH performance towards the end of the quarter. Benchmark also maintained a Buy rating but lowered its price target to $21, following a downward revision in the company’s fiscal year 2025 adjusted EBITDA forecast. This revision was linked to reimbursement penalties in the Critical Illness Recovery Hospitals segment during its seasonally strongest quarter.

Additionally, Select Medical announced a partnership with Ballad Health to operate Select Specialty Hospital – Tri-Cities in Kingsport, Tennessee, as a hospital-in-hospital facility. Select Medical will be the majority owner and managing partner of this 46-bed critical illness recovery hospital. The facility will relocate following regulatory approval, currently being operated at Ballad Health’s Bristol Regional Medical Center. Furthermore, UBS noted that Select Medical is focusing on expanding its inpatient rehabilitation facilities, reporting high occupancy rates and growth through new bed additions. These developments highlight the company’s ongoing strategic efforts in navigating regulatory landscapes and expanding its healthcare services.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.